Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo (Q46766813)

25 December 2017

title

Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo (English)

1 reference

25 December 2017

1 reference

Egerod FL

1

1 reference

25 December 2017

Nielsen HS

2

1 reference

25 December 2017

Iversen L

3

1 reference

25 December 2017

Thorup I

4

1 reference

25 December 2017

Storgaard T

5

1 reference

25 December 2017

Oleksiewicz MB

6

1 reference

25 December 2017

publication date

1 July 2005

1 reference

25 December 2017

published in

Biomarkers

1 reference

25 December 2017

volume

10

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

295-309

1 reference

25 December 2017

Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Egr transcription factors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF‐κβ

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Transformation of mammalian cells by overexpressing H2O2-generating peroxisomal fatty acyl-CoA oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

A phase II trial with rosiglitazone in liposarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Molecular targets of the oncogenic transcription factor jun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Signaling control of mRNA translation in cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Activation of immediate-early gene expression by peroxisome proliferators in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

(-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Drosophila S6 kinase: a regulator of cell size

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

PPAR trilogy from metabolism to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Peroxisome proliferators activate growth regulatory pathways largely via peroxisome proliferator-activated receptor alpha-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone beta gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Regulation of life and death by the zinc finger transcription factor Egr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500218682

10.1080/13547500500218682

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017